IPV stands for “Inactivated Poliovirus Vaccine.” It is a vaccine that is used to protect against poliomyelitis, which is a highly infectious viral disease that can cause paralysis and even death.
IPV is made from the inactivated or “killed” poliovirus and is administered through an injection. It works by stimulating the body’s immune system to produce antibodies against the poliovirus, which provide protection against the disease.
IPV is considered to be safe and effective, with very few side effects. It is usually given as part of a routine vaccination schedule for children, with the first dose given at 2 months of age and subsequent doses given at 4 and 6 months of age, and a booster dose given between the ages of 4 and 6 years.
The use of IPV has been a major factor in the global effort to eradicate polio. Since the introduction of the vaccine in the 1950s, the number of polio cases has declined dramatically, with only a few countries still reporting cases of the disease.
In conclusion, IPV is a critical tool in the fight against polio and has helped to save countless lives. Its continued use is essential to achieving the goal of eradicating this devastating disease once and for all.